IPO INDIA
![Bansal Wire IPO share allotment expected soon. Check status, GMP, listing date and other details](https://img.etimg.com/thumb/msid-111549964,width-100,height-75,resizemode-4/markets/ipos/fpos/bansal-wire-ipo-share-allotment-expected-soon-check-status-gmp-listing-date-and-other-details.jpg)
Bansal Wire IPO share allotment expected soon. Check status, GMP, listing date and other details
Bansal Wire's IPO saw strong interest with 58 times subscription. Share allotment to be finalized on Monday. Company is the largest stainless steel wire manufacturer in India, catering to various sectors. Unlisted shares trading at a premium of Rs 76.
![IPO Calendar: 1 IPO, 5 listings investors need to watch out for next week](https://img.etimg.com/thumb/msid-111531946,width-100,height-75,resizemode-4/markets/ipos/fpos/ipo-calendar-1-ipo-5-listings-investors-need-to-watch-out-for-next-week.jpg)
IPO Calendar: 1 IPO, 5 listings investors need to watch out for next week
Analysts believe that despite a temporary lull, India's strong economic fundamentals and promising growth outlook create an ideal environment for its burgeoning IPO market. They foresee significant investment in public markets and robust demand for both new-age and traditional companies in the coming months.
![At $4.2 billion, Q2 2024 IPO size records its highest growth in 2 years](https://img.etimg.com/thumb/msid-111530323,width-100,height-75,resizemode-4/markets/ipos/fpos/at-4-2-billion-q2-2024-ipo-size-records-its-highest-growth-in-2-years.jpg)
At $4.2 billion, Q2 2024 IPO size records its highest growth in 2 years
QIPs saw a rise in both value and volume compared to the previous quarter, with 20 issues raising $2.3 billion. This marks the second-highest volume since Q4 2017. The retail and consumer sector led deal activity, with an 18% increase in value over Q1 2024, despite a 7% decrease in volume.
![Emcure Pharmaceuticals IPO booked nearly 68 times so far on Day 3. Check GMP and other details](https://img.etimg.com/thumb/msid-111509263,width-100,height-75,resizemode-4/markets/ipos/fpos/emcure-pharmaceuticals-ipo-booked-over-13-times-so-far-on-day-3-check-gmp-and-other-details.jpg)
Emcure Pharmaceuticals IPO booked nearly 68 times so far on Day 3. Check GMP and other details
Emcure Pharmaceuticals IPO sees strong demand with oversubscription. Anchor investors include top names. Company engaged in global pharmaceutical products. Revenue growth and plans for debt payment outlined. Book-running lead managers identified.
![HDFC Bank invests in anchor round of this high-demand SME IPO with over 100% GMP](https://img.etimg.com/thumb/msid-111513639,width-100,height-75,resizemode-4/markets/ipos/fpos/hdfc-bank-invests-in-anchor-round-of-this-high-demand-sme-ipo-with-over-100-gmp.jpg)
HDFC Bank invests in anchor round of this high-demand SME IPO with over 100% GMP
HDFC Bank has been allocated approximately 1.58 lakh shares worth Rs 3 crore at Rs 190 each in the anchor round of the Ganesh Green Bharath IPO, which opened for subscription recently. Other notable investors in the anchor round include Copthall Mauritius Investment, India Equity Fund, and Craft Emerging Market Fund.
- Go To Page 1
Namita Thapar-backed Emcure Pharma IPO opens for subscription. Should you bid?
Emcure Pharma IPO: Emcure Pharmaceuticals IPO, with marquee investors like Goldman Sachs, offers a fresh equity issuance and OFS. Namita Thapar to earn Rs 127 crore through the stake sale. The company targets debt repayment and global expansion.
Emcure Pharmaceuticals IPO fully subscribed on Day 1. Check GMP and other details
Emcure Pharmaceuticals' IPO attracts high demand from investors, with a price range of Rs 960-1008 per share. Analysts foresee business improvements and revenue growth potential in the global pharmaceutical market, supporting the company's expansion strategies.
Emcure Pharmaceuticals IPO booked nearly 5x so far on Day 2. Check GMP and other details
Emcure Pharmaceuticals' IPO has been oversubscribed nearly three times as of Thursday, the second day of bidding. The bidding concludes on July 5. The categories reserved for NII and retail investors were subscribed the most at 13 times and 3.43 times, respectively.
Ganesh Green Bharat IPO opens today: Check issue size, price band, GMP and other details
Ganesh Green Bharat IPO will open for subscription, aiming to raise Rs 125 crore for solar and electrical projects. The company's diversified business model and strong financial performance make it a potential investment opportunity.
Ambey Laboratories opens today: Check issue size, price band, GMP & other details
Ambey Laboratories’ SME IPO, aiming to raise Rs 44.68 crore by July 8, offers shares at Rs 65-68 in lots of 2,000. With Rs 100 crore revenue and Rs 6.02 crore profit, it's set to list on NSE SME.
Renewable energy firm ACME Solar Holdings files papers for Rs 3,000-crore IPO
The Gurugram-based company's proposed IPO is a combination of fresh issue of shares worth Rs 2,000 crore and an offer for sale (OFS) of shares valued Rs 1,000 crore by ACME Cleantech Solutions, according to the DRHP. The offer also includes a reservation for a subscription by eligible employees. The company may consider issue of securities to the tune of up to Rs 400 crore as a "pre-IPO placement". If such placement is completed, the fresh issue size will be reduced.
Bansal Wire IPO: Should you subscribe to the Rs 745 cr-issue?
Bansal Wire IPO: Bansal Wire's IPO offers 2.19 crore shares, closing on July 5. Analysts recommend high-risk investors consider the IPO at a P/E ratio of 41.41x. The company plans to use funds for debt repayment, with a price band of Rs 243-256 per share.
Bansal Wire IPO sails through on Day 1 on robust NII, retail demand. Check GMP and other details
Bansal Wire's IPO saw strong demand from retail and non-institutional investors on the first day, while the QIB portion remained unsubscribed. Proceeds will be used for debt repayment, working capital, and general corporate purposes.
Hyundai India eyes record $3.5 billion IPO
Hyundai Motor India Ltd. plans to start gauging investor interest in the coming weeks, with a listing likely in September or October, the people said, asking not to be identified as the information isn’t public.
Namita Thapar's Emcure Pharmaceuticals IPO opens on Wednesday. What GMP signals ahead of subscription
Emcure Pharmaceuticals' IPO opens for subscription on July 3rd with shares trading at a Rs 265 premium in the unlisted market. The IPO includes fresh equity shares worth Rs 800 crore and an Offer For Sale (OFS) of 1.14 crore shares. Priced at Rs 960-1,008 per share, investors can bid for 14 shares per lot. The company targets to raise Rs 1,952 crore at the upper price range.
Sagility India files prospectus
EQT's Sagility India filed a DRHP for an IPO, offering 984 million equity shares. Sagility BV is the promoter. FY24 revenue reached ₹4,753 crore, setting the stage for a significant market debut.
Health insurer Niva Bupa, Sagility India files draft papers with Sebi for IPOs
The IPO, with each share having a face value of Rs 10, consists of a fresh issuance worth Rs 800 crore and an offer for sale totaling up to Rs 2,200 crore by the promoters and existing investors. As part of the OFS, Bupa Singapore Holdings and Fettle Tone will be divesting their stakes.
Bansal Wire IPO opens Wednesday: Here are 10 things to know about the public offer
The IPO of Bansal Wire is scheduled to open for subscription on July 3 and will close on July 5. The company aims to raise approximately Rs 745 crore through this public offering. This IPO consists entirely of a fresh equity sale of 2.91 crore shares, with no OFS component involved. According to market analysts, Bansal Wire currently commands a GMP of Rs 65 in the unlisted market.
Sagility India files draft papers; seeks Sebi's nod to float IPO
The company, in its draft papers filed on Friday, said that the objective of the initial share sale is to gain the advantages of listing the equity shares on the stock exchanges.
Emcure Pharmaceuticals IPO: 10 things to know before subscribing to the issue
Emcure Pharmaceuticals IPO is scheduled to open for subscription on July 3 and will close on July 5. The company aims to raise approximately Rs 1,952 crore through the public offer. Market analysts indicate that the current GMP of the pharma company stands at Rs 260 in the unlisted market.
Health insurer Niva Bupa files for Rs 3,000 crore IPO
The company, majority owned by British United Provident Fund (Bupa), said it will issue fresh shares worth up to eight billion rupees as part of the offering.It aims to use the proceeds from that sale to strengthen its balance sheet and for operating expenses.
IndiaFirst Life's IPO deferred, not shelved: Rushabh Gandhi
Gandhi said the "IPO plan has been deferred but not shelved", and will align with market conditions, which are expected to be more favourable 18 months from now. The company's earlier attempts were hindered by regulatory and market uncertainties.
73% IPOs trading above issue price as primary market shines in H1, four turn multibaggers
The fundraising of Rs 26,272 crore, however fell short of the previous two years likely due to the absence of mega issues. Investors' reception also remained positive with only one failed IPO.
Allied Blenders IPO Subscribed 23.55 Times
Allied Blenders and Distillers, India's third-largest domestic IMFL company, concludes its 1,500-crore IPO with overwhelming demand, oversubscribed 23.55 times. The offering, featuring a price band of 267-281 apiece, saw robust interest across all investor categories, reflecting confidence in its diverse portfolio of whisky, brandy, rum, vodka, and gin.
Hyundai India IPO banks set for country's 2nd biggest payday with $40 million fee: Report
The evolving financial landscape in India, characterized by the Hyundai India IPO and the rise in private company IPOs, presents significant opportunities for financial institutions like Nomura and Jefferies Financial Group to capitalize on the flourishing market and drive investment banking fees to new heights.
Fintech firm Pine Labs weighs $1 billion IPO in India
Pine Labs is reportedly considering a US IPO that could value the company at over $6 billion. The offering is expected to include both new and secondary shares, and the company may pursue a pre-IPO funding round.
Falcon Technoprojects India Limited IPO Opens on June 19, 2024
Mumbai (Maharashtra) [India], Falcon Technoprojects India Limited, has announced its plan to go public with an Initial Public Offering (IPO) on June 19, 2024. The company is aiming to raise Rs 13.69 Crore at the price of Rs 92 per share through this IPO, with shares set to be listed on the NSE Emerge platform.
Load More